SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-23-120737 from Immunome Inc. (IMNM) (CIK 0001472012) (IMNM)

Immunome Inc. (IMNM) (CIK 0001472012)
Date: Nov. 22, 2023 · CIK: 0001472012 · Accession: 0001104659-23-120737

AI Filing Summary & Sentiment

File numbers found in text: 333-275598

Date
November 22, 2023
Author
Chief Legal Officer
Form
CORRESP
Company
Immunome Inc. (IMNM) (CIK 0001472012)

Letter

Immunome, Inc.

665 Stockton Drive, Suite 300

Exton, PA 19341

November 22, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Tamika N. Sheppard

Re: Immunome, Inc.

Registration Statement on Form S-3

File No. 333-275598

Acceleration Request

Requested Date: November 27, 2023

Requested Time: 4:00 PM Eastern Time

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Immunome, Inc. hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-275598) (the “Registration Statement”) to become effective on November 27, 2023, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.

Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez at Cooley LLP at (858) 550-6157 or Dylan Kornbluth of Cooley LLP at (858) 550-6173. Thank you for your assistance with this matter.

Very truly yours,
Immunome, Inc.

Show Raw Text
CORRESP
1
filename1.htm

Immunome, Inc.

665 Stockton Drive, Suite 300

Exton, PA 19341

November 22, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Tamika N. Sheppard

 Re: Immunome, Inc.

Registration Statement
on Form S-3

File No. 333-275598

Acceleration Request

 Requested Date: November 27, 2023

 Requested Time: 4:00 PM Eastern Time

Ladies and Gentlemen:

In accordance with Rule 461
under the Securities Act of 1933, as amended, Immunome, Inc. hereby requests that the Securities and Exchange Commission take
appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-275598) (the “Registration
Statement”) to become effective on November 27, 2023, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.

Once the Registration
Statement has been declared effective, please orally confirm that event with Carlos Ramirez at Cooley LLP at (858) 550-6157 or Dylan Kornbluth
of Cooley LLP at (858) 550-6173. Thank you for your assistance with this matter.

    Very truly yours,

    Immunome, Inc.

    By:
    /s/ Sandra Stoneman

    Sandra Stoneman

    Chief Legal Officer

 cc: Thomas Coll, Cooley LLP

Carlos Ramirez, Cooley LLP

Dylan
Kornbluth, Cooley LLP